These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18779044)

  • 1. Coinfection alters the playing field: herpesviruses induce acyclovir to inhibit HIV.
    Stapleton JT; Balfour HH
    Cell Host Microbe; 2008 Sep; 4(3):194-5. PubMed ID: 18779044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues.
    Lisco A; Vanpouille C; Tchesnokov EP; Grivel JC; Biancotto A; Brichacek B; Elliott J; Fromentin E; Shattock R; Anton P; Gorelick R; Balzarini J; McGuigan C; Derudas M; Götte M; Schinazi RF; Margolis L
    Cell Host Microbe; 2008 Sep; 4(3):260-270. PubMed ID: 18779052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual Screening of Acyclovir Derivatives as Potential Antiviral Agents: Design, Synthesis, and Biological Evaluation of New Acyclic Nucleoside ProTides.
    Derudas M; Vanpouille C; Carta D; Zicari S; Andrei G; Snoeck R; Brancale A; Margolis L; Balzarini J; McGuigan C
    J Med Chem; 2017 Sep; 60(18):7876-7896. PubMed ID: 28829913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bipolar hypertrophic herpes: an unusual presentation of acyclovir-resistant herpes simplex type 2 in a HIV-infected patient.
    Cury K; Valin N; Gozlan J; Jacquier I; Boutolleau D; Guegan S; Flejou JF; Girard PM
    Sex Transm Dis; 2010 Feb; 37(2):126-8. PubMed ID: 19858782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSV therapy and HIV-1 reduction.
    Martinez V; Caumes E
    N Engl J Med; 2007 May; 356(22):2323; author reply 2324. PubMed ID: 17538093
    [No Abstract]   [Full Text] [Related]  

  • 6. Sensitivity of V75I HIV-1 reverse transcriptase mutant selected in vitro by acyclovir to anti-HIV drugs.
    McMahon MA; Siliciano JD; Kohli RM; Siliciano RF
    AIDS; 2010 Jan; 24(2):319-23. PubMed ID: 20009920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.
    Schacker T; Zeh J; Hu H; Shaughnessy M; Corey L
    J Infect Dis; 2002 Dec; 186(12):1718-25. PubMed ID: 12447756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emergence of acyclovir resistance in mucocutaneous herpes simplex viral infections: implications for clinical practice.
    Grodesky MJ
    Nurse Pract; 1997 Jun; 22(6):155-6. PubMed ID: 9211458
    [No Abstract]   [Full Text] [Related]  

  • 9. Antivirals in the context of HIV disease.
    Wood MJ
    J Antimicrob Chemother; 1996 May; 37 Suppl B():97-112. PubMed ID: 8818833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoramidate derivatives of acyclovir: synthesis and antiviral activity in HIV-1 and HSV-1 models in vitro.
    Zakirova NF; Shipitsyn AV; Jasko MV; Prokofjeva MM; Andronova VL; Galegov GA; Prassolov VS; Kochetkov SN
    Bioorg Med Chem; 2012 Oct; 20(19):5802-9. PubMed ID: 22954898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical presentations of genital herpes simplex virus in HIV-1 and HIV-2 effectively treated by imiquimod.
    McKendry A; Narayana S; Browne R
    Int J STD AIDS; 2015 May; 26(6):441-3. PubMed ID: 24912536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aciclovir for dual infection with HIV and HSV.
    Verjans GM; Boucher CA
    Lancet Infect Dis; 2012 Jun; 12(6):424-5. PubMed ID: 22433278
    [No Abstract]   [Full Text] [Related]  

  • 13. Surgical excision for recurrent herpes simplex virus 2 (HSV-2) anogenital infection in a patient with human immunodeficiency virus (HIV).
    Arinze F; Shaver A; Raffanti S
    Infection; 2017 Oct; 45(5):705-707. PubMed ID: 28508238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consistent inhibition of HIV-1 replication in CD4+ T cells by acyclovir without detection of human herpesviruses.
    McMahon MA; Parsons TL; Shen L; Siliciano JD; Siliciano RF
    J Virol; 2011 May; 85(9):4618-22. PubMed ID: 21325417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-collected genital swabs compared with cervicovaginal lavage for measuring HIV-1 and HSV-2 and the effect of acyclovir on viral shedding.
    McNicholl JM; Leelawiwat W; Whitehead S; Hanson DL; Evans-Strickfaden T; Cheng CY; Chonwattana W; Mueanpai F; Kittinunvorakoon C; Markowitz L; Dunne EF
    Int J STD AIDS; 2017 Mar; 28(4):372-379. PubMed ID: 27179350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficiency of combined therapy of herpes virus infection in HIV infected patients].
    Papuashvili MN; Shchelkanov MIu
    Vopr Virusol; 2004; 49(2):25-9. PubMed ID: 15106380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fulminant, acyclovir-resistant, herpes simplex virus type 2 hepatitis in an immunocompetent woman.
    Czartoski T; Liu C; Koelle DM; Schmechel S; Kalus A; Wald A
    J Clin Microbiol; 2006 Apr; 44(4):1584-6. PubMed ID: 16597901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new acyclic heterodinucleotide active against human immunodeficiency virus and herpes simplex virus.
    Franchetti P; Abu Sheikha G; Cappellacci L; Marchetti S; Grifantini M; Balestra E; Perno C; Benatti U; Brandi G; Rossi L; Magnani M
    Antiviral Res; 2000 Sep; 47(3):149-58. PubMed ID: 10974367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How does herpes simplex virus type 2 influence human immunodeficiency virus infection and pathogenesis?
    Wald A; Corey L
    J Infect Dis; 2003 May; 187(10):1509-12. PubMed ID: 12721930
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of acyclovir-resistant herpes simplex virus type 2 proctitis with leflunomide in an HIV-infected man.
    Henao-Martínez AF; Weinberg A; Waldman WJ; Levi ME
    J Clin Virol; 2012 Jul; 54(3):276-8. PubMed ID: 22465339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.